In a market that has seen its fair share of volatility, Progenity Inc (BIOR) stock has managed to reach a 52-week high, touching the $5.2 mark. This peak comes as a notable point in the stock's recent ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that it has entered into definitive ...
InvestingPro Insights While Progenity Inc (BIOR) has recently touched a 52-week high of $5.2, InvestingPro data reveals a more complex financial picture. The company's market capitalization stands at ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...